As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access challenges and payer coverage trends affecting treatment options.

The Alliance for Pharmacy Compounding (APC), a trade organisation ... and quality before they are marketed." Tirzepatide was removed from the shortages list a few weeks ago, leading to ...

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

The US drugmaker has stolen a march on Novo Nordisk by bringing a viable oral weight-loss medicine, orforglipron, into successful phase 3 clinical trials. An oral version is the holy grail for drugs ...

The launch of the NovoCare Pharmacy service ... obesity products from compounding pharmacies, which have been able to offer discounted versions of semaglutide and tirzepatide under FDA regulations ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.